Worldwide Clinical trials benefits
At Worldwide Clinical Trials you benefit from outstanding expertise in the field of cardiovascular research. Our global cardiovascular team incorporates experience in the practice of cardiology, advanced scientific research with novel chemical entities and more than 20 years of conducting complex global cardiovascular clinical studies.
Our expertise and reputation for generating data of impeccable quality allows us to maintain close relationships with key opinion leaders and practitioners within the field, which transcribes into superior results and reliable recruitment for your study.
Phase I–IV Experience includes:
- Coronary artery disease, including acute coronary syndrome
- Arterial hypertension
- Heart failure/left ventricular dysfunction
- Peripheral vascular disease
Large Outcomes Trials – Expertise On Any Scale
Cardiovascular studies enroll thousands of patients across the world in centers that are representative of the practicing community in the region, and have outcomes that can affect standards of care. Patient eligibility criteria is often highly inclusive and outcome measures are medically significant (e.g. all-cause mortality, cardiac death and major cardiovascular disability). The nature of these trials places a premium on scalable infrastructure.
We fully adapt for randomization and deliver you operational acumen alongside team personalization and communication strategies that coordinate multiple centres and vendors.
- Flexible data management services
- Experienced clinical drug supply management
- Highly coordinated clinical trial management services
- An ability to manage data flow and reporting for event adjudication purpose
Stemedica Posts Alzheimer's Stem Cell Data — Drug Discovery & Development
Stemedica International S.A., a Stemedica Cell Technologies Inc. subsidiary developing stem cell therapies for Alzheimer's disease and dementia, revealed the first results of an intravenous administration of allogeneic, human, ischemia-tolerant ..
New partnership brings more personalized cancer treatment to Philadelphia — Phys.Org
"Our participation in the WIN consortium means Jefferson cancer patients will have access to worldwide clinical trials on promising and individualized therapies," says Massimo Cristofanilli, M.D., Director of the Jefferson Breast Care Center. "It ..
Core Science FlexCore Joint Support, Veggie Caps 90 ea
Health and Beauty (AB)
Sambucol Sambucol Black Elderberry Immune - 4 Oz